ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Houston, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Cancer
Ovarian Cancer
Colorectal Cancer
Squamous Cell Carcinoma of Head and Neck

Breast Cancer trials near Houston, TX, USA:

Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer

the safety and preliminary efficacy of olaparib and vorinostat when used together in participants with relapsed/refractory and or metastatic breast...

Active, not recruiting
Breast Cancer
Breast Cancer Metastatic
Drug: Olaparib
Drug: Vorinostat

Phase 1

The Methodist Hospital Research Institute (TMHRI)
The Methodist Hospital Research Institute (TMHRI)

Houston, Texas, United States

This research study is evaluating how well Breast Cancer responds to preoperative treatment with Endocrine treatment in combination ...

Active, not recruiting
Breast Cancer
Drug: Endocrine Therapy
Drug: Tamoxifen

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Houston, Texas, United States and 10 other locations

This research is to evaluate the effectiveness of Talazoparib as a potential treatment for metastatic breast cancer with a BRCA 1 o...

Enrolling
Breast Cancer
Drug: Talazoparib

Phase 2

Mass General Brigham
Mass General Brigham

Houston, Texas, United States and 6 other locations

works in treating HER2-negative (HER2-low or HER2-0) metastatic breast cancer.The names of the study drugs involved in this study a...

Enrolling
Breast Cancer
HER2-low Breast Cancer
Drug: Trastuzumab Deruxtecan
Drug: Datopotamab Deruxtecan

Phase 2

Ana C Garrido-Castro, MD

Houston, Texas, United States and 10 other locations

triple negative (TN) or hormone receptor positive/HER2-negative breast cancer.The names of the study interventions involved in this...

Active, not recruiting
Hormone Receptor Positive (HR+), HER2-negative Breast Cancer
Triple Negative Breast Cancer
Drug: Paclitaxel
Drug: Carboplatin

Phase 2

Laura M. Spring, MD

Houston, Texas, United States and 9 other locations

therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...

Active, not recruiting
Breast Cancer
Hormone Receptor Positive Breast Cancer
Drug: ADJUVANT ENDOCRINE THERAPY
Combination Product: Pertuzumab+TRASTUZUMAB

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Houston, Texas, United States and 31 other locations

This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...

Active, not recruiting
Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Houston, Texas, United States and 9 other locations

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Interferon infiltration of the inoculation site

Phase 3

BriaCell Therapeutics

Webster, Texas, United States and 78 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Active, not recruiting
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

Houston, Texas, United States and 32 other locations

This research study is studying a combination of drugs as a possible treatment for breast cancer.The drugs involved in this study a...

Active, not recruiting
Breast Cancer
Drug: Utomilumab
Drug: Vinorelbine

Phase 2

Adrienne G. Waks

Houston, Texas, United States and 16 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems